These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2215761)
1. [Drugs after 1992; a comparison with yet many unknowns]. Boer EJ Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1863-7. PubMed ID: 2215761 [No Abstract] [Full Text] [Related]
2. [Generics: authorization to market and quality guarantees]. De Muylder JA Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480 [TBL] [Abstract][Full Text] [Related]
3. [Increased commercial financing of national Medical Product Agencies within the EU]. Ramel B Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381 [No Abstract] [Full Text] [Related]
4. [Are children getting the right drugs?]. Bratlid D Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3290-2. PubMed ID: 16327857 [TBL] [Abstract][Full Text] [Related]
5. [The Medical Product Agency's work and economics--a comment]. Ahlqvist Rastad J; Salmonson T Lakartidningen; 2003 Jan; 100(5):345. PubMed ID: 12607382 [No Abstract] [Full Text] [Related]
6. [Drug control within the EEC I: coordination during the 1990's]. Strandberg K Lakartidningen; 1992 Jan; 89(3):100-1. PubMed ID: 1734132 [No Abstract] [Full Text] [Related]
7. [European registration of drugs; consequences for prescriber and patient]. van Grootheest AC Ned Tijdschr Geneeskd; 1997 Jun; 141(26):1305-6. PubMed ID: 9380178 [No Abstract] [Full Text] [Related]
8. [1992: pills without limits?]. Offerhaus L Ned Tijdschr Geneeskd; 1990 Apr; 134(16):821-7. PubMed ID: 2336124 [No Abstract] [Full Text] [Related]
9. [Veterinary Drug 'what'? Various marginal notes by an 'industrial veterinarian']. Hoftijzer J Tijdschr Diergeneeskd; 1987 Apr; 112(8):481-5. PubMed ID: 3576584 [TBL] [Abstract][Full Text] [Related]
10. Governments pledge to clamp down on counterfeit drugs. Watson R BMJ; 2011 Nov; 343():d7096. PubMed ID: 22045993 [No Abstract] [Full Text] [Related]
11. [Dutch drug registration: greater openness is urgently desired]. Toenders WG; van Loenhout JW Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2051-4. PubMed ID: 9550762 [TBL] [Abstract][Full Text] [Related]
12. [European drug policy]. Sauer F Bull Mem Acad R Med Belg; 1993; 148(5-6):207-12; discussion 212-6. PubMed ID: 8142930 [TBL] [Abstract][Full Text] [Related]
13. The evaluation of drugs: whose responsibility? CIOMS Round Table Conference, October 1968. WHO Chron; 1969 Jun; 23(6):256-63. PubMed ID: 5793987 [No Abstract] [Full Text] [Related]
14. Multi-level governance: The way forward for European illicit drug policy? Chatwin C Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875 [TBL] [Abstract][Full Text] [Related]
15. [Recent initiatives of the European Union on the field of drug use and trafficking]. Salazar L Ann Ist Super Sanita; 2002; 38(3):319-21. PubMed ID: 12645184 [TBL] [Abstract][Full Text] [Related]
16. Same drug, different dosing: differences in dosing for drugs approved in the United States, Europe, and Japan. Malinowski HJ; Westelinck A; Sato J; Ong T J Clin Pharmacol; 2008 Aug; 48(8):900-8. PubMed ID: 18524997 [TBL] [Abstract][Full Text] [Related]
17. [Parallel import of drugs]. Rygnestad T; Fredriksen G; Spigset O Tidsskr Nor Laegeforen; 1999 Apr; 119(11):1573. PubMed ID: 10385794 [No Abstract] [Full Text] [Related]
18. [EURO-Medicines: a European program for bringing into agreement public health policies on drugs]. Calamo-Specchia F; Bucci R; Folino-Gallo P Ann Ig; 1998; 10(5-6):405-12. PubMed ID: 10052204 [No Abstract] [Full Text] [Related]
19. Special section. The evaluation of drugs: an international perspective. Int J Technol Assess Health Care; 1986; 2(4):613-708. PubMed ID: 10280881 [No Abstract] [Full Text] [Related]
20. European regulator is urged to release data on drugs approved in past 10 years. Kmietowicz Z BMJ; 2013 Sep; 347():f5905. PubMed ID: 24081901 [No Abstract] [Full Text] [Related] [Next] [New Search]